Date and Time | Title | |
---|---|---|
Jul 13, 2022 9:00am - 10:55am (Pacific) | Session I: Endocrine Part 1 9:00 AM PT | Welcome 9:10 AM PT | Pituitary Adenomas and Incidentalomas 10:00 AM PT | Adrenal Adenomas and Incidentalomas 10:40 AM PT | Panel Discussion *Please note, Polling questions are not activated for On-Demand content. | ![]() |
Jul 13, 2022 10:55am - 11:25am (Pacific) | Visit Sponsors and Activity Lounge | |
Jul 13, 2022 11:25am - 1:02pm (Pacific) | Session I: Endocrine Part 2 11:25 AM PT | Cushing Syndrome/Disease 12:00 PM PT | The What When How and Why of Adrenal Insufficiency 12:45 PM PT | Panel Discussion | ![]() |
Jul 13, 2022 1:15pm - 2:01pm (Pacific) | Treatment After Metformin: What Are Your Options? Explore the roles of native GLP-1 in T2D pathophysiology. Review the recommendations from national association guidelines on the treatment options after metformin in the T2D treatment algorithm. Evaluate the efficacy and safety results from a monotherapy trial of a once-daily GLP-1 RA as well as 2 other head-to-head clinical trials, including vs an SGLT-2i and a DPP-4i. Evaluate the safety data from a cardiovascular outcomes trial, followed by dosing and administration information. This is a Non-CE/CME Presentation Sponsored by Novo Nordisk | |
Jul 13, 2022 2:01pm - 2:30pm (Pacific) | Visit Sponsors and Activity Lounge | |
Jul 13, 2022 2:30pm - 5:30pm (Pacific) | Session I: Endocrine Part 3 2:30 PM PT | Hypothyroidism Tips on Management 3:10 PM PT | Hot Topics in Hyperthyroidism 3:50 PM PT | Panel Discussion 4:05 PM PT | Hot Topics in Thyroiditis 4:40 PM PT | Thyroid Nodules: Work-up, Surveillance, and Referral 5:15 PM PT | Panel Discussion *Please note, Polling questions are not activated for On-Demand content. | ![]() |
Jul 14, 2022 9:00am - 11:08am (Pacific) | Session II: Diabetes Management Part 1 9:00 AM PT | Welcome 9:10 AM PT | Prediabetes and T2D Risk Factors, Screening, and Clinical Considerations 9:40 AM PT | Type 2 Diabetes-Harmonizing Glucose Management With Cardiovascular Disease, Heart Failure and Chronic Kidney Disease Risk Reduction: Case Presentations 10:50 AM PT | Panel Discussion *Please note, Polling questions are not activated for On-Demand content. | ![]() |
Jul 14, 2022 11:09am - 11:55am (Pacific) | Visit Sponsors and Activity Lounge | |
Jul 14, 2022 11:55am - 12:55pm (Pacific) | Session II: Diabetes Management Part 2 Welcome 11:55 AM PT | Diabetes Distress and Burnout 12:25 AM PT | Adult Onset Type 1 Diabetes: How do I Proceed The Diabetes Sleuth *Please note, Polling questions are not activated for On-Demand content. | ![]() |
Jul 14, 2022 1:15pm - 2:02pm (Pacific) | Dexcom G6: A Game Changer for Patients and Practice You have the opportunity to actually see diabetes, and this can be a game changer. Dexcom G6 real-time continuous glucose monitor (CGM) allows patients with diabetes to view glucose in real time and empower self-management decisions. In addition, providers can assess these patterns and variability to create a therapeutic plan. A solution-based approach to diabetes management can improve the lives of those living with diabetes as well as those providing care. We will explore professional guidelines for diabetes management and discuss how to apply them in practice. You will learn about Dexcom G6 Pro and implementing it into a busy practice. In addition, there will be discussion about discovery learning through the experience of a person who is able to see diabetes using a Dexcom G6 CGM and make impactful behavior changes. Dexcom G6 can guide therapeutic management of diabetes, improve time in range and empower self-management. All of this helps both patient and provider. This is a Non-CE/CME Presentation Sponsored by Dexcom | |
Jul 14, 2022 2:00pm - 2:30pm (Pacific) | Visit Sponsors and Activity Lounge | |
Jul 14, 2022 2:30pm - 5:00pm (Pacific) | Session III: Diabetes and Other Critical Considerations Welcome 2:30 PM PT | Initiating Insulin: Why, When, and Which Types Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES 3:20 PM PT | Addressing Cost of Diabetes Treatments 3:50 PM PT | Diabetes and the Kidney. Screening, Prevention and Treatment 4:40 PM PT | Panel Discussion *Please note, Polling questions are not activated for On-Demand content. | ![]() |
Jul 15, 2022 7:45am - 8:33am (Pacific) | An Overview of the FSL2 System This is a Non-CE/CME Presentation Sponsored by Abbott | |
Jul 15, 2022 11:11am - 11:40am (Pacific) | Visit Sponsors and Activity Lounge | |
Jul 15, 2022 1:02pm - 2:00pm (Pacific) | Visit Sponsors and Activity Lounge | |
Jul 16, 2022 7:45am - 8:23am (Pacific) | Thyroid Replacement Options for You and Your Patients This is a Non-CE/CME Presentation Sponsored by Acella Pharma
| |
Jul 16, 2022 10:53am - 11:10am (Pacific) | Visit Sponsors and Activity Lounge |